BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

992 related articles for article (PubMed ID: 30342844)

  • 1. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.
    Gandaglia G; Martini A; Ploussard G; Fossati N; Stabile A; De Visschere P; Borgmann H; Heidegger I; Steinkohl F; Kretschmer A; Marra G; Mathieu R; Surcel C; Tilki D; Tsaur I; Valerio M; Van den Bergh R; Ost P; Gontero P; Montorsi F; Briganti A;
    Eur Urol; 2020 Aug; 78(2):138-142. PubMed ID: 32268944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
    Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
    Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.
    Gandaglia G; Barletta F; Robesti D; Scuderi S; Rajwa P; Gomez Rivas J; Ibanez L; Soeterik TFW; Bianchi L; Afferi L; Kesch C; Darr C; Guo H; Zhuang J; Zattoni F; Fendler W; Marra G; Stabile A; Amparore D; Huebner NA; Giesen A; Joniau S; Schiavina R; Brunocilla E; Mattei A; Dal Moro F; Sierra JM; Porpiglia F; Picchio M; van den Bergh R; Shariat SF; Montorsi F; Briganti A
    Eur Urol Oncol; 2023 Dec; 6(6):543-552. PubMed ID: 37270378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging.
    Di Trapani E; Luzzago S; Peveri G; Catellani M; Ferro M; Cordima G; Mistretta FA; Bianchi R; Cozzi G; Alessi S; Matei DV; Bagnardi V; Petralia G; Musi G; De Cobelli O
    Urol Oncol; 2021 Jul; 39(7):431.e15-431.e22. PubMed ID: 33423938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion.
    Oderda M; Diamand R; Albisinni S; Calleris G; Carbone A; Falcone M; Fiard G; Gandaglia G; Marquis A; Marra G; Parola C; Pastore A; Peltier A; Ploussard G; Roumeguère T; Sanchez-Salas R; Simone G; Smelzo S; Witt JH; Gontero P
    BJU Int; 2021 Mar; 127(3):318-325. PubMed ID: 32869940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
    Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study.
    Diamand R; Oderda M; Albisinni S; Fourcade A; Fournier G; Benamran D; Iselin C; Fiard G; Descotes JL; Assenmacher G; Svistakov I; Peltier A; Simone G; Di Cosmo G; Roche JB; Bonnal JL; Van Damme J; Rossi M; Mandron E; Gontero P; Roumeguère T
    Urol Oncol; 2020 Nov; 38(11):847.e9-847.e16. PubMed ID: 32466877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Hinev AI; Anakievski D; Kolev NH; Hadjiev VI
    Urol Int; 2014; 92(3):300-5. PubMed ID: 24480972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
    Walz J; Bladou F; Rousseau B; Laroche J; Salem N; Gravis G; Briganti A; Chun FK; Karakiewicz PI; Fournier G
    Urology; 2012 Mar; 79(3):546-51. PubMed ID: 22386393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography.
    Vis AN; Meijer D; Roberts MJ; Siriwardana AR; Morton A; Yaxley JW; Samaratunga H; Emmett L; van de Ven PM; Heymans MW; Nieuwenhuijzen JA; van der Poel HG; Donswijk ML; Boellaard TN; Schoots IG; Stricker P; Haynes AM; Oprea-Lager DE; Coughlin GD; van Leeuwen PJ
    Eur Urol Oncol; 2023 Dec; 6(6):553-563. PubMed ID: 37045707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection.
    Hansen J; Rink M; Bianchi M; Kluth LA; Tian Z; Ahyai SA; Shariat SF; Briganti A; Steuber T; Fisch M; Graefen M; Karakiewicz PI; Chun FK
    Prostate; 2013 Jan; 73(2):211-8. PubMed ID: 22821742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
    Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA
    Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and internal validation of a novel nomogram for predicting lymph node invasion for prostate cancer patients undergoing extended pelvic lymph node dissection.
    Li Z; Huang Y; Zhao D; Luo X; Wu Z; Zheng X; Xie Y; Liu Y; Wu J; Peng Y; Li Y; Zhou F
    Front Oncol; 2023; 13():1186319. PubMed ID: 37223684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients.
    Hueting TA; Cornel EB; Somford DM; Jansen H; van Basten JA; Pleijhuis RG; Korthorst RA; van der Palen JAM; Koffijberg H
    Eur Urol Oncol; 2018 Oct; 1(5):411-417. PubMed ID: 31158080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.
    Grivas N; Wit E; Tillier C; van Muilekom E; Pos F; Winter A; van der Poel H
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2213-2226. PubMed ID: 28780722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A machine learning-assisted decision-support model to better identify patients with prostate cancer requiring an extended pelvic lymph node dissection.
    Hou Y; Bao ML; Wu CJ; Zhang J; Zhang YD; Shi HB
    BJU Int; 2019 Dec; 124(6):972-983. PubMed ID: 31392808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era.
    Frego N; Paciotti M; Buffi NM; Maffei D; Contieri R; Avolio PP; Fasulo V; Uleri A; Lazzeri M; Hurle R; Saita A; Guazzoni GF; Casale P; Lughezzani G
    Front Surg; 2022; 9():829515. PubMed ID: 35284478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.